QVT Financial LP - Q4 2022 holdings

$1.9 Billion is the total value of QVT Financial LP's 52 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 50.0% .

 Value Shares↓ Weighting
SellROIVANT SCIENCES LTD$979,106,873
+135.0%
122,541,536
-5.3%
51.63%
+77.6%
MP SellMP MATERIALS CORP$327,818,314
-12.1%
13,501,578
-1.1%
17.28%
-33.6%
SPY  SPDR S&P 500 ETF TRput$181,654,250
+7.1%
475,0000.0%9.58%
-19.1%
NXST  NEXSTAR MEDIA GROUP INC$29,008,597
+4.9%
165,7350.0%1.53%
-20.7%
BuyNIO INCnote 4.500% 2/0$28,215,702
-26.6%
22,250,000
+3.5%
1.49%
-44.5%
GS BuyGOLDMAN SACHS GROUP INC$27,491,690
+95.7%
80,062
+67.0%
1.45%
+48.0%
BuyIQIYI INCnote 2.000% 4/0$24,822,724
+11.7%
30,279,000
+19.8%
1.31%
-15.6%
 PALO ALTO NETWORKS INCnote 0.750% 7/0$23,730,125
-14.8%
15,000,0000.0%1.25%
-35.6%
NNI  NELNET INCcl a$19,480,849
+14.6%
214,6650.0%1.03%
-13.4%
CHK  CHESAPEAKE ENERGY CORP$17,392,297
+0.2%
184,2990.0%0.92%
-24.3%
BuyGDS HLDGS LTDnote 2.000% 6/0$16,791,979
+12.3%
17,500,000
+9.4%
0.88%
-15.1%
ATEX  ANTERIX INC$16,211,782
-9.9%
503,9410.0%0.86%
-31.9%
BRKB  BERKSHIRE HATHAWAY INC DELcl b new$14,810,519
+15.7%
47,9460.0%0.78%
-12.5%
MMYT  MAKEMYTRIP LIMITED MAURITIUS$13,536,346
-10.2%
490,9810.0%0.71%
-32.1%
BuySEA LTDnote 0.250% 9/1$12,992,516
+24.5%
17,600,000
+17.3%
0.68%
-5.9%
ARGX  ARGENX SEsponsored adr$12,311,217
+7.3%
32,4980.0%0.65%
-19.0%
NewNOBLE CORP PLC$12,219,925324,050
+100.0%
0.64%
NYT  NEW YORK TIMES COcl a$10,288,100
+12.9%
316,9470.0%0.54%
-14.8%
 STRIDE INCnote 1.125% 9/0$8,971,723
-12.2%
10,000,0000.0%0.47%
-33.7%
VIAC SellPARAMOUNT GLOBAL$8,633,799
-24.5%
511,481
-14.8%
0.46%
-43.0%
CCL NewCARNIVAL CORP$8,060,0001,000,000
+100.0%
0.42%
CCL NewCARNIVAL CORPput$8,060,0001,000,000
+100.0%
0.42%
 EAGLE BULK SHIPPING INCnote 5.000% 8/0$8,029,102
+13.8%
4,850,0000.0%0.42%
-14.0%
IMGN  IMMUNOGEN INC$6,824,464
+3.8%
1,375,9000.0%0.36%
-21.6%
MSTR BuyMICROSTRATEGY INCcl a new$6,628,874
+89.7%
46,824
+184.4%
0.35%
+43.4%
NewENVIVA INCput$6,621,250125,000
+100.0%
0.35%
MSTR  MICROSTRATEGY INCput$6,597,162
-33.3%
46,6000.0%0.35%
-49.6%
 MAKEMYTRIP LIMITED MAURITIUSnote 2/1$6,459,602
-5.2%
6,500,0000.0%0.34%
-28.2%
ALLT  ALLOT LTD$6,044,854
-12.2%
1,757,2250.0%0.32%
-33.7%
ILMN SellILLUMINA INC$5,176,320
-50.0%
25,600
-52.8%
0.27%
-62.2%
NIO NewNIO INCput$4,875,000500,000
+100.0%
0.26%
 REDFIN CORPnote 1.750% 7/1$4,748,368
+4.1%
5,000,0000.0%0.25%
-21.4%
FSR NewFISKER INCput$4,362,000600,000
+100.0%
0.23%
IOVA  IOVANCE BIOTHERAPEUTICS INC$4,336,024
-33.3%
678,5640.0%0.23%
-49.6%
VTNR BuyVERTEX ENERGY INCput$3,425,500
+21.5%
552,500
+22.1%
0.18%
-8.1%
TNK SellTEEKAY TANKERS LTDcl a$3,335,491
-34.1%
108,260
-41.1%
0.18%
-50.1%
GTN  GRAY TELEVISION INC$3,261,348
-21.9%
291,4520.0%0.17%
-40.9%
IQ NewIQIYI INCput$2,650,000500,000
+100.0%
0.14%
NewH WORLD GROUP LTDnote 3.000% 5/0$2,425,9502,000,000
+100.0%
0.13%
FRO NewFRONTLINE LTD$1,992,599164,135
+100.0%
0.10%
JD SellJD.COM INCspon adr cl a$1,811,540
-44.2%
32,274
-50.0%
0.10%
-57.7%
NewBILIBILI INCnote 0.500%12/0$1,476,6082,000,000
+100.0%
0.08%
 JOYY INCnote 0.750% 6/1$953,235
+2.3%
1,000,0000.0%0.05%
-23.1%
BuyNUSCALE PWR CORP*w exp 05/02/202$795,000
+28.4%
500,000
+67.2%
0.04%
-2.3%
BMRN  BIOMARIN PHARMACEUTICAL INC$458,357
+22.2%
4,4290.0%0.02%
-7.7%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$423,977
-44.9%
4,813
-50.0%
0.02%
-59.3%
SRPT  SAREPTA THERAPEUTICS INC$403,901
+17.1%
3,1170.0%0.02%
-12.5%
MRSN  MERSANA THERAPEUTICS INC$367,170
-13.4%
62,6570.0%0.02%
-36.7%
ACAD  ACADIA PHARMACEUTICALS INC$312,239
-2.7%
19,6130.0%0.02%
-27.3%
NewSELINA HOSPITALITY PLCordinary shares$67,75025,000
+100.0%
0.00%
APPHW  APPHARVEST INC*w exp 01/29/202$47,550
-72.0%
500,0000.0%0.00%
-75.0%
NewSELINA HOSPITALITY PLC*w exp 10/27/202$11,593144,913
+100.0%
0.00%
GDS ExitGDS HLDGS LTDsponsored ads$0-17,700
-100.0%
-0.02%
TIL ExitINSTIL BIO INC$0-98,644
-100.0%
-0.03%
CLVS ExitCLOVIS ONCOLOGY INCput$0-505,000
-100.0%
-0.04%
BIDU ExitBAIDU INCspon adr rep a$0-5,200
-100.0%
-0.04%
ACMR ExitACM RESH INC$0-70,119
-100.0%
-0.06%
FRG ExitFRANCHISE GROUP INC$0-130,120
-100.0%
-0.22%
LBTYA ExitLIBERTY GLOBAL PLC$0-242,800
-100.0%
-0.26%
CLVS ExitCLOVIS ONCOLOGY INC$0-3,525,000
-100.0%
-0.29%
NIO ExitNIO INCcall$0-300,000
-100.0%
-0.33%
ExitH WORLD GROUP LTDnote 0.375%11/0$0-4,780,000
-100.0%
-0.33%
NE ExitNOBLE CORP NEW$0-257,294
-100.0%
-0.53%
LILAK ExitLIBERTY LATIN AMERICA LTD$0-1,749,467
-100.0%
-0.75%
ExitCLOVIS ONCOLOGY INCnote 4.500% 8/0$0-21,000,000
-100.0%
-0.89%
ExitMICROSTRATEGY INCnote 0.750%12/1$0-20,000,000
-100.0%
-1.07%
ExitCARNIVAL CORPnote 5.750% 4/0$0-16,000,000
-100.0%
-1.17%
ILMN ExitILLUMINA INCcall$0-146,200
-100.0%
-1.95%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings